ONCOGENE 润色咨询

ONCOGENE

出版年份：1987 年文章数：9343 投稿命中率： 开通期刊会员，数据随心看

出版周期：Weekly 自引率：3.3% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964380, encodeId=9179964380d2, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向： 肿瘤 <br>经验分享：20210507投稿一篇Review，现在情况是这样子的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210510/f742c0a85f5e49c19b3f17cd09b21317.png, type=image, width=513, height=249)], authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Mon May 10 21:26:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921971, encodeId=d8b39219e12d, content=有大神知道oncogene的conflict声明怎么写吗？需要提供单独的文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eorec7qJdIyT1ebjhWQ0DWjicDnPwKY0eTP2jPqQDicWkFUUwsD9T9KXyt1p7HvD7edPaeq0AibqURicg/132, createdBy=2af72299758, createdName=chamonix2016, createdTime=Mon Feb 01 16:35:33 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919964, encodeId=a74c919964dc, content=各位大佬，请问这个杂志送审后接受率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Tue Jan 26 10:50:25 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811883, encodeId=0b56811883f7, content=收藏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Fri Aug 21 18:09:32 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800431, encodeId=de19800431d2, content=7.971分，今年📈回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 22:15:53 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590579, encodeId=8dd15905e9ef, content=最近有人投oncogene 吗？编辑审核也很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 12:42:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590569, encodeId=2fa3590569d1, content=投稿老师给了邮箱，没给密码，所以看不到邮件qcstarted4天了状态还是没动，编辑审核这么久吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 08:26:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589378, encodeId=fb8c5893e837, content=如果是修回，状态会是waiting for revision，莫不是直接接受了？<span class="quote">187pnZI2775(暂无昵称) 2020-04-19 发表::<br>研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span><span class="quote">187pnZI2775(暂无昵称) 2020-04-19 23:44:00 发表:<br>求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span>, beContent=187pnZI2775(暂无昵称) 2020-04-19 发表:: 研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61192150804, createdName=189200e3c9m, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=)]
    2021-07-15 cindichaw

    去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964380, encodeId=9179964380d2, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向： 肿瘤 <br>经验分享：20210507投稿一篇Review，现在情况是这样子的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210510/f742c0a85f5e49c19b3f17cd09b21317.png, type=image, width=513, height=249)], authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Mon May 10 21:26:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921971, encodeId=d8b39219e12d, content=有大神知道oncogene的conflict声明怎么写吗？需要提供单独的文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eorec7qJdIyT1ebjhWQ0DWjicDnPwKY0eTP2jPqQDicWkFUUwsD9T9KXyt1p7HvD7edPaeq0AibqURicg/132, createdBy=2af72299758, createdName=chamonix2016, createdTime=Mon Feb 01 16:35:33 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919964, encodeId=a74c919964dc, content=各位大佬，请问这个杂志送审后接受率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Tue Jan 26 10:50:25 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811883, encodeId=0b56811883f7, content=收藏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Fri Aug 21 18:09:32 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800431, encodeId=de19800431d2, content=7.971分，今年📈回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 22:15:53 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590579, encodeId=8dd15905e9ef, content=最近有人投oncogene 吗？编辑审核也很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 12:42:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590569, encodeId=2fa3590569d1, content=投稿老师给了邮箱，没给密码，所以看不到邮件qcstarted4天了状态还是没动，编辑审核这么久吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 08:26:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589378, encodeId=fb8c5893e837, content=如果是修回，状态会是waiting for revision，莫不是直接接受了？<span class="quote">187pnZI2775(暂无昵称) 2020-04-19 发表::<br>研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span><span class="quote">187pnZI2775(暂无昵称) 2020-04-19 23:44:00 发表:<br>求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span>, beContent=187pnZI2775(暂无昵称) 2020-04-19 发表:: 研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61192150804, createdName=189200e3c9m, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=)]
    2021-07-08 代攻悯

    无

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964380, encodeId=9179964380d2, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向： 肿瘤 <br>经验分享：20210507投稿一篇Review，现在情况是这样子的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210510/f742c0a85f5e49c19b3f17cd09b21317.png, type=image, width=513, height=249)], authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Mon May 10 21:26:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921971, encodeId=d8b39219e12d, content=有大神知道oncogene的conflict声明怎么写吗？需要提供单独的文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eorec7qJdIyT1ebjhWQ0DWjicDnPwKY0eTP2jPqQDicWkFUUwsD9T9KXyt1p7HvD7edPaeq0AibqURicg/132, createdBy=2af72299758, createdName=chamonix2016, createdTime=Mon Feb 01 16:35:33 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919964, encodeId=a74c919964dc, content=各位大佬，请问这个杂志送审后接受率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Tue Jan 26 10:50:25 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811883, encodeId=0b56811883f7, content=收藏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Fri Aug 21 18:09:32 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800431, encodeId=de19800431d2, content=7.971分，今年📈回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 22:15:53 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590579, encodeId=8dd15905e9ef, content=最近有人投oncogene 吗？编辑审核也很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 12:42:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590569, encodeId=2fa3590569d1, content=投稿老师给了邮箱，没给密码，所以看不到邮件qcstarted4天了状态还是没动，编辑审核这么久吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 08:26:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589378, encodeId=fb8c5893e837, content=如果是修回，状态会是waiting for revision，莫不是直接接受了？<span class="quote">187pnZI2775(暂无昵称) 2020-04-19 发表::<br>研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span><span class="quote">187pnZI2775(暂无昵称) 2020-04-19 23:44:00 发表:<br>求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span>, beContent=187pnZI2775(暂无昵称) 2020-04-19 发表:: 研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61192150804, createdName=189200e3c9m, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=)]
    2021-05-10 ruiruima

    精彩评论，需要您登录查看

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964380, encodeId=9179964380d2, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向： 肿瘤 <br>经验分享：20210507投稿一篇Review，现在情况是这样子的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210510/f742c0a85f5e49c19b3f17cd09b21317.png, type=image, width=513, height=249)], authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Mon May 10 21:26:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921971, encodeId=d8b39219e12d, content=有大神知道oncogene的conflict声明怎么写吗？需要提供单独的文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eorec7qJdIyT1ebjhWQ0DWjicDnPwKY0eTP2jPqQDicWkFUUwsD9T9KXyt1p7HvD7edPaeq0AibqURicg/132, createdBy=2af72299758, createdName=chamonix2016, createdTime=Mon Feb 01 16:35:33 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919964, encodeId=a74c919964dc, content=各位大佬，请问这个杂志送审后接受率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Tue Jan 26 10:50:25 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811883, encodeId=0b56811883f7, content=收藏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Fri Aug 21 18:09:32 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800431, encodeId=de19800431d2, content=7.971分，今年📈回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 22:15:53 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590579, encodeId=8dd15905e9ef, content=最近有人投oncogene 吗？编辑审核也很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 12:42:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590569, encodeId=2fa3590569d1, content=投稿老师给了邮箱，没给密码，所以看不到邮件qcstarted4天了状态还是没动，编辑审核这么久吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 08:26:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589378, encodeId=fb8c5893e837, content=如果是修回，状态会是waiting for revision，莫不是直接接受了？<span class="quote">187pnZI2775(暂无昵称) 2020-04-19 发表::<br>研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span><span class="quote">187pnZI2775(暂无昵称) 2020-04-19 23:44:00 发表:<br>求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span>, beContent=187pnZI2775(暂无昵称) 2020-04-19 发表:: 研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61192150804, createdName=189200e3c9m, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=)]
    2021-02-01 chamonix2016

    有大神知道oncogene的conflict声明怎么写吗？需要提供单独的文件？

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964380, encodeId=9179964380d2, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向： 肿瘤 <br>经验分享：20210507投稿一篇Review，现在情况是这样子的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210510/f742c0a85f5e49c19b3f17cd09b21317.png, type=image, width=513, height=249)], authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Mon May 10 21:26:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921971, encodeId=d8b39219e12d, content=有大神知道oncogene的conflict声明怎么写吗？需要提供单独的文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eorec7qJdIyT1ebjhWQ0DWjicDnPwKY0eTP2jPqQDicWkFUUwsD9T9KXyt1p7HvD7edPaeq0AibqURicg/132, createdBy=2af72299758, createdName=chamonix2016, createdTime=Mon Feb 01 16:35:33 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919964, encodeId=a74c919964dc, content=各位大佬，请问这个杂志送审后接受率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Tue Jan 26 10:50:25 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811883, encodeId=0b56811883f7, content=收藏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Fri Aug 21 18:09:32 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800431, encodeId=de19800431d2, content=7.971分，今年📈回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 22:15:53 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590579, encodeId=8dd15905e9ef, content=最近有人投oncogene 吗？编辑审核也很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 12:42:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590569, encodeId=2fa3590569d1, content=投稿老师给了邮箱，没给密码，所以看不到邮件qcstarted4天了状态还是没动，编辑审核这么久吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 08:26:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589378, encodeId=fb8c5893e837, content=如果是修回，状态会是waiting for revision，莫不是直接接受了？<span class="quote">187pnZI2775(暂无昵称) 2020-04-19 发表::<br>研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span><span class="quote">187pnZI2775(暂无昵称) 2020-04-19 23:44:00 发表:<br>求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span>, beContent=187pnZI2775(暂无昵称) 2020-04-19 发表:: 研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61192150804, createdName=189200e3c9m, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=)]
    2021-01-26 洋娃娃

    各位大佬，请问这个杂志送审后接受率高吗？

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964380, encodeId=9179964380d2, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向： 肿瘤 <br>经验分享：20210507投稿一篇Review，现在情况是这样子的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210510/f742c0a85f5e49c19b3f17cd09b21317.png, type=image, width=513, height=249)], authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Mon May 10 21:26:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921971, encodeId=d8b39219e12d, content=有大神知道oncogene的conflict声明怎么写吗？需要提供单独的文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eorec7qJdIyT1ebjhWQ0DWjicDnPwKY0eTP2jPqQDicWkFUUwsD9T9KXyt1p7HvD7edPaeq0AibqURicg/132, createdBy=2af72299758, createdName=chamonix2016, createdTime=Mon Feb 01 16:35:33 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919964, encodeId=a74c919964dc, content=各位大佬，请问这个杂志送审后接受率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Tue Jan 26 10:50:25 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811883, encodeId=0b56811883f7, content=收藏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Fri Aug 21 18:09:32 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800431, encodeId=de19800431d2, content=7.971分，今年📈回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 22:15:53 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590579, encodeId=8dd15905e9ef, content=最近有人投oncogene 吗？编辑审核也很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 12:42:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590569, encodeId=2fa3590569d1, content=投稿老师给了邮箱，没给密码，所以看不到邮件qcstarted4天了状态还是没动，编辑审核这么久吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 08:26:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589378, encodeId=fb8c5893e837, content=如果是修回，状态会是waiting for revision，莫不是直接接受了？<span class="quote">187pnZI2775(暂无昵称) 2020-04-19 发表::<br>研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span><span class="quote">187pnZI2775(暂无昵称) 2020-04-19 23:44:00 发表:<br>求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span>, beContent=187pnZI2775(暂无昵称) 2020-04-19 发表:: 研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61192150804, createdName=189200e3c9m, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=)]
    2020-08-21 站在塔尖

    收藏

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964380, encodeId=9179964380d2, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向： 肿瘤 <br>经验分享：20210507投稿一篇Review，现在情况是这样子的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210510/f742c0a85f5e49c19b3f17cd09b21317.png, type=image, width=513, height=249)], authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Mon May 10 21:26:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921971, encodeId=d8b39219e12d, content=有大神知道oncogene的conflict声明怎么写吗？需要提供单独的文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eorec7qJdIyT1ebjhWQ0DWjicDnPwKY0eTP2jPqQDicWkFUUwsD9T9KXyt1p7HvD7edPaeq0AibqURicg/132, createdBy=2af72299758, createdName=chamonix2016, createdTime=Mon Feb 01 16:35:33 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919964, encodeId=a74c919964dc, content=各位大佬，请问这个杂志送审后接受率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Tue Jan 26 10:50:25 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811883, encodeId=0b56811883f7, content=收藏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Fri Aug 21 18:09:32 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800431, encodeId=de19800431d2, content=7.971分，今年📈回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 22:15:53 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590579, encodeId=8dd15905e9ef, content=最近有人投oncogene 吗？编辑审核也很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 12:42:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590569, encodeId=2fa3590569d1, content=投稿老师给了邮箱，没给密码，所以看不到邮件qcstarted4天了状态还是没动，编辑审核这么久吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 08:26:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589378, encodeId=fb8c5893e837, content=如果是修回，状态会是waiting for revision，莫不是直接接受了？<span class="quote">187pnZI2775(暂无昵称) 2020-04-19 发表::<br>研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span><span class="quote">187pnZI2775(暂无昵称) 2020-04-19 23:44:00 发表:<br>求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span>, beContent=187pnZI2775(暂无昵称) 2020-04-19 发表:: 研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61192150804, createdName=189200e3c9m, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=)]
    2020-06-29 mswert122

    7.971分，今年📈回来了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964380, encodeId=9179964380d2, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向： 肿瘤 <br>经验分享：20210507投稿一篇Review，现在情况是这样子的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210510/f742c0a85f5e49c19b3f17cd09b21317.png, type=image, width=513, height=249)], authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Mon May 10 21:26:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921971, encodeId=d8b39219e12d, content=有大神知道oncogene的conflict声明怎么写吗？需要提供单独的文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eorec7qJdIyT1ebjhWQ0DWjicDnPwKY0eTP2jPqQDicWkFUUwsD9T9KXyt1p7HvD7edPaeq0AibqURicg/132, createdBy=2af72299758, createdName=chamonix2016, createdTime=Mon Feb 01 16:35:33 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919964, encodeId=a74c919964dc, content=各位大佬，请问这个杂志送审后接受率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Tue Jan 26 10:50:25 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811883, encodeId=0b56811883f7, content=收藏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Fri Aug 21 18:09:32 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800431, encodeId=de19800431d2, content=7.971分，今年📈回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 22:15:53 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590579, encodeId=8dd15905e9ef, content=最近有人投oncogene 吗？编辑审核也很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 12:42:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590569, encodeId=2fa3590569d1, content=投稿老师给了邮箱，没给密码，所以看不到邮件qcstarted4天了状态还是没动，编辑审核这么久吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 08:26:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589378, encodeId=fb8c5893e837, content=如果是修回，状态会是waiting for revision，莫不是直接接受了？<span class="quote">187pnZI2775(暂无昵称) 2020-04-19 发表::<br>研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span><span class="quote">187pnZI2775(暂无昵称) 2020-04-19 23:44:00 发表:<br>求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span>, beContent=187pnZI2775(暂无昵称) 2020-04-19 发表:: 研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61192150804, createdName=189200e3c9m, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=)]
    2020-05-10 146f239fm10(暂无昵称)

    最近有人投oncogene 吗？编辑审核也很慢吗？

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964380, encodeId=9179964380d2, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向： 肿瘤 <br>经验分享：20210507投稿一篇Review，现在情况是这样子的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210510/f742c0a85f5e49c19b3f17cd09b21317.png, type=image, width=513, height=249)], authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Mon May 10 21:26:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921971, encodeId=d8b39219e12d, content=有大神知道oncogene的conflict声明怎么写吗？需要提供单独的文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eorec7qJdIyT1ebjhWQ0DWjicDnPwKY0eTP2jPqQDicWkFUUwsD9T9KXyt1p7HvD7edPaeq0AibqURicg/132, createdBy=2af72299758, createdName=chamonix2016, createdTime=Mon Feb 01 16:35:33 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919964, encodeId=a74c919964dc, content=各位大佬，请问这个杂志送审后接受率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Tue Jan 26 10:50:25 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811883, encodeId=0b56811883f7, content=收藏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Fri Aug 21 18:09:32 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800431, encodeId=de19800431d2, content=7.971分，今年📈回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 22:15:53 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590579, encodeId=8dd15905e9ef, content=最近有人投oncogene 吗？编辑审核也很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 12:42:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590569, encodeId=2fa3590569d1, content=投稿老师给了邮箱，没给密码，所以看不到邮件qcstarted4天了状态还是没动，编辑审核这么久吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 08:26:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589378, encodeId=fb8c5893e837, content=如果是修回，状态会是waiting for revision，莫不是直接接受了？<span class="quote">187pnZI2775(暂无昵称) 2020-04-19 发表::<br>研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span><span class="quote">187pnZI2775(暂无昵称) 2020-04-19 23:44:00 发表:<br>求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span>, beContent=187pnZI2775(暂无昵称) 2020-04-19 发表:: 研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61192150804, createdName=189200e3c9m, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=)]
    2020-05-10 146f239fm10(暂无昵称)

    投稿老师给了邮箱，没给密码，所以看不到邮件qcstarted4天了状态还是没动，编辑审核这么久吗？

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=999607, encodeId=b56c99960ec0, content=去年通讯了一篇，感觉比较严谨，抓细节。改了两个月，接收。新颖性和意义要求比不上cancer res，但总体差距不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:02:30 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997716, encodeId=db4499e7165c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1625453153, createdName=代攻悯, createdTime=Thu Jul 08 23:01:36 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964380, encodeId=9179964380d2, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向： 肿瘤 <br>经验分享：20210507投稿一篇Review，现在情况是这样子的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210510/f742c0a85f5e49c19b3f17cd09b21317.png, type=image, width=513, height=249)], authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Mon May 10 21:26:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921971, encodeId=d8b39219e12d, content=有大神知道oncogene的conflict声明怎么写吗？需要提供单独的文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eorec7qJdIyT1ebjhWQ0DWjicDnPwKY0eTP2jPqQDicWkFUUwsD9T9KXyt1p7HvD7edPaeq0AibqURicg/132, createdBy=2af72299758, createdName=chamonix2016, createdTime=Mon Feb 01 16:35:33 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919964, encodeId=a74c919964dc, content=各位大佬，请问这个杂志送审后接受率高吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Tue Jan 26 10:50:25 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811883, encodeId=0b56811883f7, content=收藏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Fri Aug 21 18:09:32 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800431, encodeId=de19800431d2, content=7.971分，今年📈回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 22:15:53 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590579, encodeId=8dd15905e9ef, content=最近有人投oncogene 吗？编辑审核也很慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 12:42:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590569, encodeId=2fa3590569d1, content=投稿老师给了邮箱，没给密码，所以看不到邮件qcstarted4天了状态还是没动，编辑审核这么久吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=146f239fm10(暂无昵称), createdTime=Sun May 10 08:26:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589378, encodeId=fb8c5893e837, content=如果是修回，状态会是waiting for revision，莫不是直接接受了？<span class="quote">187pnZI2775(暂无昵称) 2020-04-19 发表::<br>研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span><span class="quote">187pnZI2775(暂无昵称) 2020-04-19 23:44:00 发表:<br>求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态</span>, beContent=187pnZI2775(暂无昵称) 2020-04-19 发表:: 研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61192150804, createdName=189200e3c9m, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=)]
    2020-04-21 189200e3c9m

    如果是修回，状态会是waiting for revision，莫不是直接接受了？187pnZI2775(暂无昵称) 2020-04-19 发表::
    研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态    187pnZI2775(暂无昵称) 2020-04-19 23:44:00 发表:
    求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态

    187pnZI2775(暂无昵称) 2020-04-19 发表:: 研究方向：肿瘤;免疫; 审稿时间：约3个月 求助大神，我投稿的oncogene，外审结束后，最近刚刚decision made，但是导师账号的邮箱写错了，没收到意见。要怎么处理比较好。另外，能不能判断文章拒了没？现在是post decision manuscripts的状态

    0

共500条页码: 9/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分